A Shropshire hospital trust has received more than £460,000 in government payments for removing 14,148 patients from its waiting lists. The Shrewsbury and Telford Hospital NHS Trust (SaTH) took part in three nationally coordinated exercises between April 2025 and March 2026, each designed to strip out entries deemed inaccurate or no longer necessary.

The exercises, known as "validation sprints", are government-sponsored reviews in which NHS trusts examine their waiting lists and remove patients who no longer require treatment or whose records appear more than once. Trusts receive £33 for each confirmed removal, referred to as a clock stop. SaTH participated in sprints running across April 2025, July to September 2025, and January to March 2026, accumulating its total payment across all three rounds.

Ned Hobbs, the trust's chief operating officer and deputy chief executive, said the exercises served two purposes: reducing the visible backlog and ensuring the waiting list reflected genuine clinical demand. He attributed part of the problem to a recent migration from one data system to another, which he said had left legacy data issues that artificially inflated the figures. "It helped reduce backlogs while ensuring waiting lists more accurately reflected true demand," he said.

The trust's recorded performance has improved considerably over the period in question. SaTH was required to have at least 60 per cent of patients waiting no longer than 18 weeks by March 2026. In November 2024, when NHS England established its baseline, 48.5 per cent of patients met that threshold. By February 2026, that figure had risen to 63.1 per cent. The trust has attributed part of that improvement to a £24 million elective surgery hub that opened in Telford in 2024, along with changes to outpatient services and diagnostic capacity. In December 2024, it received a separate £2 million payment from NHS England as a reward for cutting waiting times, at which point its overall list had reduced by 10,000 and the number of children waiting for treatment had fallen by 40 per cent.

The validation process has not gone without scrutiny. At a board meeting in March, Gill George, a campaigner with Shropshire, Telford and Wrekin Defend Our NHS, asked what recourse patients had if they believed they had been wrongly removed from the list. Hobbs said patients could raise the matter with their GP. That answer has done little to satisfy those who question whether the process is sufficiently transparent. There is no formal appeals mechanism within the trust itself, and patients may be unaware they have been removed at all.

The broader concern is whether validation sprints, however administratively justified, provide a convenient means of reducing waiting list numbers without a corresponding reduction in unmet need. Trusts are paid per removal, which creates a financial incentive to find removable entries. When a system migration has also introduced data errors, as SaTH has acknowledged, it becomes harder to distinguish between cleaning up genuine duplicates and quietly clearing patients who may still require care.

SaTH is not unique in this regard. Validation sprints have been used across English NHS trusts as part of the government's effort to bear down on waiting list figures inherited from the post-pandemic period. The payments are framed as compensation for the administrative work involved rather than as incentives, though the effect is the same: trusts that remove more patients receive more money.

Whether the figures now reported by SaTH represent a genuine improvement in capacity, a correction of inflated historical data, or some combination of both is difficult to determine from the outside. What is clear is that tens of thousands of patients have been removed from the list, a significant financial payment has been made, and the mechanism for challenging those removals remains limited to a conversation with a GP.